Orca Capital AG 13D and 13G filings for Can-Fite BioPharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 4:30 pm Purchase |
2025-04-14 | 13G | Can-Fite BioPharma Ltd. CANF |
Orca Capital AG | 375,000,000 9.700% |
375,000,000 (New Position) |
Filing |